STOCK TITAN

[Form 4] EASTMAN CHEMICAL CO Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Eastman Chemical (EMN) director Renee J. Hornbaker reported an automatic deferral under the Directors' Deferred Compensation Plan. On 10/07/2025, she was credited with 487 phantom stock units (value equal to one share of common stock), at a price of $0, reflecting a portion of her annual retainer fees. Phantom units are payable only in cash after service as a director ends.

Following the transaction, she beneficially owned 49,781 derivative securities. This total includes 1,151 units credited since April 7, 2025 as hypothetical reinvestment of dividend equivalents.

Eastman Chemical (EMN), la direttrice Renee J. Hornbaker ha riportato una rinuncia automatica ai sensi del Directors' Deferred Compensation Plan. Il 10/07/2025 le è stato accreditato 487 unità azionarie fantasma (valore pari a una azione ordinaria), a un prezzo di $0, riflettendo una parte delle sue fee annuali di trattenimento. Le unità fantasma sono pagabili solo in contanti dopo la cessazione della funzione di amministratore.

Dopo la transazione, ella deteneva effettivamente 49.781 strumenti derivati. Questo totale include 1.151 unità accreditate dal 7 aprile 2025 come reinvestimento ipotetico delle quote di dividendi.

Eastman Chemical (EMN), la directora Renee J. Hornbaker, informó una aplazamiento automático bajo el Plan de Compensación Diferida para Directores. El 07/10/2025 recibió crédito de 487 unidades fantasma de acciones (valor equivalente a una acción común), a un precio de $0, reflejando una parte de sus honorarios anuales de retención. Las unidades fantasma solo se pagan en efectivo una vez que termina el servicio como directora.

Después de la transacción, ella poseía beneficiosamente 49.781 valores derivados. Este total incluye 1.151 unidades acreditadas desde el 7 de abril de 2025 como reinversión hipotética de las equivalentes de dividendos.

Eastman Chemical (EMN) 이사 Renee J. Hornbaker는 이사 보상계획(Directors' Deferred Compensation Plan) 아래 자동 연기(deferral)를 보고했습니다. 2025년 10월 7일에 그녀는 487 가상 주식 단위를 적립받았으며(일반주식 1주와 동일한 가치), 가격은 $0로, 연간 유지비의 일부를 반영합니다. 가상 단위는 이사가 끝난 후 현금으로만 지급됩니다.

거래 후, 그녀는 실질적으로 49,781 파생 증권을 보유하게 되었습니다. 이 합계는 2025년 4월 7일 이후로 배당수익의 가상 재투자로 적립된 1,151단위를 포함합니다.

Eastman Chemical (EMN), la directrice Renee J. Hornbaker a signalé un report automatique dans le cadre du Directors' Deferred Compensation Plan. Le 07/10/2025, elle a été créditée de 487 unités d'actions fantômes (valeur égale à une action ordinaire), à un prix de 0 $, reflétant une partie de ses frais annuels de retenue. Les unités fantômes ne sont payables qu'en espèces après la fin du mandat en tant que directrice.

Suite à la transaction, elle possedait effectivement 49 781 titres dérivés. Ce total inclut 1 151 unités créditées depuis le 7 avril 2025 comme réinvestissement hypothétique des équivalents de dividendes.

Eastman Chemical (EMN) Direktorin Renee J. Hornbaker meldete eine automatische Verschiebung gemäß dem Directors' Deferred Compensation Plan. Am 07.10.2025 wurde sie mit 487 Phantomaktien-Einheitengutgeschrieben (Wert entspricht einer Aktie der Stammaktien), zu einem Preis von 0 $, was einen Teil ihrer jährlichen Retainer-Gebühren widerspiegelt. Phantom-Einheiten sind nach Beendigung der Tätigkeit als Direktor nur in bar zahlbar.

Nach der Transaktion besaß sie effektiv 49.781 Derivate Wertpapiere. Dieser Gesamtbetrag umfasst 1.151 Einheiten, die seit dem 7. April 2025 als hypothetische Reinvestition von Dividendenäquivalenten gutgeschrieben wurden.

Eastman Chemical (EMN) مديرة Renee J. Hornbaker أبلغت عن تأجيل تلقائي بموجب خطة تعويضات المدراء المؤجلة. في 10/07/2025، تم اعتماد 487 وحدة أسهم شبحية (قيمة تساوي سهم واحد من الأسهم العادية)، بسعر 0 دولار، يعكس جزءاً من أتعاب الاحتفاظ السنوية لها. الوحدات الشبحية قابلة للدفع فقط نقداً بعد انتهاء الخدمة كمديرة.

بعد الصفقة، أصبحت تمتلك فعلياً 49,781 أداة مشتقة. يشمل هذا الإجمالي 1,151 وحدة مُعتمدة منذ 7 أبريل 2025 كإعادة استثمار افتراضية لمكافئ توزيعات الأرباح.

Eastman Chemical (EMN) 董事 Renee J. Hornbaker 报告了在董事延期薪酬计划下的自动延期。在 2025/10/07,她获得了 487 虚拟股票单位(等同于一股普通股的价值),价格为 $0,反映了她年度保留费的一部分。虚拟单位在担任董事期间结束后才以现金支付。

交易后,她实际拥有 49,781 衍生证券。此总数 包括自 2025 年 4 月 7 日以来因股息等价 reinvestment 的 1,151 单位

Positive
  • None.
Negative
  • None.

Eastman Chemical (EMN), la direttrice Renee J. Hornbaker ha riportato una rinuncia automatica ai sensi del Directors' Deferred Compensation Plan. Il 10/07/2025 le è stato accreditato 487 unità azionarie fantasma (valore pari a una azione ordinaria), a un prezzo di $0, riflettendo una parte delle sue fee annuali di trattenimento. Le unità fantasma sono pagabili solo in contanti dopo la cessazione della funzione di amministratore.

Dopo la transazione, ella deteneva effettivamente 49.781 strumenti derivati. Questo totale include 1.151 unità accreditate dal 7 aprile 2025 come reinvestimento ipotetico delle quote di dividendi.

Eastman Chemical (EMN), la directora Renee J. Hornbaker, informó una aplazamiento automático bajo el Plan de Compensación Diferida para Directores. El 07/10/2025 recibió crédito de 487 unidades fantasma de acciones (valor equivalente a una acción común), a un precio de $0, reflejando una parte de sus honorarios anuales de retención. Las unidades fantasma solo se pagan en efectivo una vez que termina el servicio como directora.

Después de la transacción, ella poseía beneficiosamente 49.781 valores derivados. Este total incluye 1.151 unidades acreditadas desde el 7 de abril de 2025 como reinversión hipotética de las equivalentes de dividendos.

Eastman Chemical (EMN) 이사 Renee J. Hornbaker는 이사 보상계획(Directors' Deferred Compensation Plan) 아래 자동 연기(deferral)를 보고했습니다. 2025년 10월 7일에 그녀는 487 가상 주식 단위를 적립받았으며(일반주식 1주와 동일한 가치), 가격은 $0로, 연간 유지비의 일부를 반영합니다. 가상 단위는 이사가 끝난 후 현금으로만 지급됩니다.

거래 후, 그녀는 실질적으로 49,781 파생 증권을 보유하게 되었습니다. 이 합계는 2025년 4월 7일 이후로 배당수익의 가상 재투자로 적립된 1,151단위를 포함합니다.

Eastman Chemical (EMN), la directrice Renee J. Hornbaker a signalé un report automatique dans le cadre du Directors' Deferred Compensation Plan. Le 07/10/2025, elle a été créditée de 487 unités d'actions fantômes (valeur égale à une action ordinaire), à un prix de 0 $, reflétant une partie de ses frais annuels de retenue. Les unités fantômes ne sont payables qu'en espèces après la fin du mandat en tant que directrice.

Suite à la transaction, elle possedait effectivement 49 781 titres dérivés. Ce total inclut 1 151 unités créditées depuis le 7 avril 2025 comme réinvestissement hypothétique des équivalents de dividendes.

Eastman Chemical (EMN) Direktorin Renee J. Hornbaker meldete eine automatische Verschiebung gemäß dem Directors' Deferred Compensation Plan. Am 07.10.2025 wurde sie mit 487 Phantomaktien-Einheitengutgeschrieben (Wert entspricht einer Aktie der Stammaktien), zu einem Preis von 0 $, was einen Teil ihrer jährlichen Retainer-Gebühren widerspiegelt. Phantom-Einheiten sind nach Beendigung der Tätigkeit als Direktor nur in bar zahlbar.

Nach der Transaktion besaß sie effektiv 49.781 Derivate Wertpapiere. Dieser Gesamtbetrag umfasst 1.151 Einheiten, die seit dem 7. April 2025 als hypothetische Reinvestition von Dividendenäquivalenten gutgeschrieben wurden.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
HORNBAKER RENEE J

(Last) (First) (Middle)
200 S. WILCOX DRIVE

(Street)
KINGSPORT TN 37660

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
EASTMAN CHEMICAL CO [ EMN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/07/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Phantom Stock Units $0(1) 10/07/2025 A 487(2) (1) (1) Common Stock 487(2) $0(2) 49,781(3) D
Explanation of Responses:
1. Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to one share of issuer common stock and payable only in cash after termination of service as a director.
2. Automatic deferral of a portion of director's annual retainer fees into the director's stock account of the Directors' Deferred Compensation Plan, which would otherwise have been paid in cash.
3. Includes 1,151 units credited since April 7, 2025 as hypothetical reinvestment of dividend equivalents.
Remarks:
/s/ Mark D. Austin, by Power of Attorney for Renee J. Hornbaker 10/09/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did EMN director Renee J. Hornbaker report on Form 4?

She reported 487 phantom stock units credited on 10/07/2025 under the Directors' Deferred Compensation Plan.

What is the price and form of the reported EMN derivative award?

The phantom stock units were recorded at a price of $0 as part of an automatic deferral of director retainer fees.

How many derivative securities does the EMN director hold after the transaction?

She beneficially owned 49,781 derivative securities following the transaction.

How are EMN phantom stock units settled?

They are payable only in cash after termination of service as a director.

Do EMN phantom units reflect dividend equivalents?

Yes. The total includes 1,151 units credited since April 7, 2025 as hypothetical reinvestment of dividend equivalents.

Why were the EMN units credited to the director?

They reflect an automatic deferral of a portion of the director’s annual retainer fees into the plan’s stock account.
Eastman Chem Co

NYSE:EMN

EMN Rankings

EMN Latest News

EMN Latest SEC Filings

EMN Stock Data

6.68B
113.81M
0.78%
91.74%
2.59%
Specialty Chemicals
Plastic Materials, Synth Resins & Nonvulcan Elastomers
Link
United States
KINGSPORT